Abstract

The increasing number of infections caused by multidrug-resistant bacteria requires an intensified search for new antibiotics. Pep19-4LF is a synthetic antimicrobial peptide (GKKYRRFRWKFKGKLFLFG) that was previously designed with the main focus on high antimicrobial activity. The hydrophobic motif, LFLFG, was found to be essential for antimicrobial activity. However, this motif shows several limitations such as aggregation in biological media, low solubility, and small yields in peptide synthesis. In order to obtain more appropriate peptide characteristics, the hydrophobic motif was replaced with fatty acids. For this purpose, a shortened variant of Pep19-4LF (Pep19-short; GKKYRRFRWKFKGK) was synthesized and covalently linked to saturated fatty acids of different chain lengths. The peptide conjugates were tested with respect to their antibacterial activity by microdilution experiments on different bacterial strains. The length of the fatty acid was found to be directly correlated to the antimicrobial activity up to an ideal chain length (undecanoic acid, C11:0). This conjugate showed high antimicrobial activity in absence of toxicity. Time–kill studies revealed a fast and bactericidal mode of action. Furthermore, the first in vivo experiments of the conjugate in rodents demonstrated pharmacokinetics appropriate for application as a drug. These results clearly indicate that the hydrophobic motif of the peptide can be replaced by a single fatty acid of medium length, simplifying the design of this antimicrobial peptide while retaining high antimicrobial activity in the absence of toxicity.

Highlights

  • The synthetic anti-lipopolysaccharide peptide Pep19-2.5 (GCKKYRRFRWKFKGKFWFWG) was designed to bind and neutralize pathogen-associated molecular patterns (PAMPs) [1]

  • minimal inhibitory concentrations (MICs) values were determined to investigate the antimicrobial potential of the conjugates on MICbacterial values were determined to investigate the antimicrobial of the (MIC)

  • The high MIC value of Pep19-short indicates the importance of a hydrophobic moiety for this

Read more

Summary

Introduction

The synthetic anti-lipopolysaccharide peptide Pep19-2.5 (GCKKYRRFRWKFKGKFWFWG) was designed to bind and neutralize pathogen-associated molecular patterns (PAMPs) [1]. Sepsis is induced by PAMPs, including lipopolysaccharides (LPS) from Gram-negative bacteria and lipoproteins (LP). Derived from Gram-positive bacteria [2]. These virulence factors represent the main components. Antibiotics 2020, 9, 844 of bacterial cell membranes. This results in a strong cytokine secretion, damaging tissue and organs [3]. In this context Pep19-2.5 has been proven to bind and neutralize free LPS and LP in the bloodstream [1]; antiseptic/anti-inflammatory effects could be demonstrated in vivo in mouse models [4]. Pep19-2.5, inhibits the effects of cytoplasmic LPS in human myeloid cells and keratinocytes [5]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.